Cerus Corporation
Nasdaq CERS · Concord, CA
Works in Genetic & rare · Hematology · Immunology · Infectious disease · Respiratory
Cerus Corporation is a clinical trial sponsor based in Concord, CA, listed as Nasdaq CERS. It has 3 active clinical trials with 465 planned participants, across 5 therapeutic areas. Since 2021 it has completed 5 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq CERS
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Cerus Corporation
Cerus Corporation is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 465 planned participants, in Genetic & rare, Hematology, Immunology, Infectious disease and other areas. Since 2021 it has completed 5 trials and stopped 2 early.
Cerus Corporation is based in Concord, CA and is listed as Nasdaq CERS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Cerus Corporation; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-14.
Approve Suite is not affiliated with Cerus Corporation.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.